PCD-CT<i>Versus</i>EID-CT in Imaging of Pancreatic Ductal Adenocarcinoma: A Prospective Comparative Pilot Study
PCD-CT offers a novel method with potential benefits in imaging of pancreatic tumours. Further development of the protocol, including optimisation and validation in larger cohorts of patients, are necessary to define a potential role of PCD-CT in the management of PDAC.
Authors
- Erik Tesselaar (ORCID: https://orcid.org/0000-0002-8387-0583)
- Mischa Woisetschläger (ORCID: https://orcid.org/0000-0003-0066-4985)
- Michael Sandborg (ORCID: https://orcid.org/0000-0003-3352-8330)
- Nils Elander (ORCID: https://orcid.org/0000-0001-9345-0278)
- Wolf Bartholomä (ORCID: https://orcid.org/0000-0002-6897-2717)
- Bergþór Björnsson (ORCID: https://orcid.org/0000-0001-9704-1260)
- Hakon Blomstrand (ORCID: https://orcid.org/0000-0002-9845-1410)
- Tomas Bjerner (ORCID: https://orcid.org/0000-0001-9548-4842)
Institutions
- Linköping University (SE)
- Linköping University Hospital (SE)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.21873/anticanres.17536
- Citations
- 2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09